ENZO BIOCHEM INC (ENZ)

US2941001024 - Common Stock

0.7222  +0.02 (+3.17%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ENZO BIOCHEM INC

NYSE:ENZ (12/18/2024, 11:00:31 AM)

0.7222

+0.02 (+3.17%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-37.5%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap38.03M
Shares
PEN/A
Fwd PEN/A
Dividend Yield14.29%
Analysts
Short Float %
Short Ratio
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ENZ Daily chart

Company Profile

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company is headquartered in Farmingdale, New York and currently employs 125 full-time employees. The firm's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The firm monetizes its technology primarily via sales through its global distribution network and licensing. The firm conducts its research and other product development efforts through internal research and collaborative relationships.

Company Info

ENZO BIOCHEM INC

60 Executive Blvd

Farmingdale NEW YORK 10022

P: 15167555500

CEO: Elazar Rabbani

Employees: 185

Website: https://www.enzo.com/

ENZ News

ChartMill News Image20 hours ago - ChartmillThese stocks are moving in today's session

Tuesday's session: top gainers and losers

News Imagea day ago - Market News VideoTuesday Sector Laggards: Diagnostics, Railroads
News Image2 days ago - Enzo Biochem, Inc. Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...

News Image2 months ago - Enzo Biochem, Inc. Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...

News Image6 months ago - InvestorPlaceENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024

Enzo Biochem just reported results for the third quarter of 2024.

News Image6 months ago - BusinessInsiderENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the third quarter of 2024.Enz...

ENZ Twits

Here you can normally see the latest stock twits on ENZ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example